Rock Springs Capital Management LP Q3 2021 Filing
Filed November 15, 2021
Portfolio Value
$4.8B
Holdings
153
Report Date
Q3 2021
Filing Type
13F-HR
All Holdings (153 positions)
| Stock | Value |
|---|---|
APLTAPPLIED THERAPEUTICS INC | $11.6M |
PRLDPRELUDE THERAPEUTICS INC | $11.3M |
ADAPYADAPTIMMUNE THERAPEUTICS PLC | $11.3M |
TREURTRILLIUM THERAPEUTICS INC | $11.0M |
—ORION ACQUISITION CORP | $9.9M |
INZYINOZYME PHARMA INC | $9.9M |
SPRBSPRUCE BIOSCIENCES INC | $9.7M |
AM6AMICUS THERAPEUTICS INC | $9.7M |
NRIXNURIX THERAPEUTICS INC | $9.5M |
DAWNDAY ONE BIOPHARMACEUTICALS I | $8.9M |
XENEXENON PHARMACEUTICALS INC | $8.9M |
290ACHINOOK THERAPEUTICS INC | $8.8M |
OKURRENEO PHARMACEUTICALS INC | $8.5M |
—GAMIDA CELL LTD | $8.4M |
—PARATEK PHARMACEUTICALS INC | $8.1M |
RYTMRHYTHM PHARMACEUTICALS INC | $8.0M |
—F-STAR THERAPEUTICS INC | $7.7M |
—KINNATE BIOPHARMA INC | $7.7M |
CGENCOMPUGEN LTD | $7.7M |
—FUSION PHARMACEUTICALS INC | $7.5M |
—EARGO INC | $6.6M |
FATEFATE THERAPEUTICS INC | $6.5M |
STTKSHATTUCK LABS INC | $6.4M |
—PHASEBIO PHARMACEUTICALS INC | $5.7M |
—ATHIRA PHARMA INC | $5.2M |
TBPHTHERAVANCE BIOPHARMA INC | $5.1M |
DSGNDESIGN THERAPEUTICS INC | $4.9M |
EDAEDAP TMS S A | $4.9M |
ATAIATAI LIFE SCIENCES NV | $4.7M |
GRTXGALERA THERAPEUTICS INC | $4.6M |
OVASUSDTEMPEST THERAPEUTICS INC | $4.5M |
EPIEURESSA PHARMA INC | $4.1M |
—ACELRX PHARMACEUTICALS INC | $3.9M |
INNVINNOVAGE HLDG CORP | $3.5M |
—IMARA INC | $3.4M |
TVTX 2.5 09/15/25TRAVERE THERAPEUTICS INC | $3.3M |
—BCLS ACQUISITION CORP | $3.1M |
BCELATRECA INC | $2.9M |
NUVBNUVATION BIO INC | $2.4M |
PSTXUSDPOSEIDA THERAPEUTICS INC | $2.1M |
—FS DEVELOPMENT CORP II | $2.1M |
—EUCRATES BIOMEDICAL ACQU COR | $2.0M |
—TURMERIC ACQUISITION CORP | $2.0M |
—POPULATION HEALTH INVS CO IN | $2.0M |
—JIYA ACQUISITION CORP | $2.0M |
MLTXHELIX ACQUISITION CORP | $1.5M |
—THERAVANCE BIOPHARMA INC | $1.4M |
—RADIUS HEALTH INC | $1.4M |
NBIX 2.25 05/15/24NEUROCRINE BIOSCIENCES INC | $1.3M |
—PACIRA BIOSCIENCES INC | $1.0M |
APLSAPELLIS PHARMACEUTICALS INC | $872K |
NVRO 2.75 04/01/25NEVRO CORP | $675K |
NUVB/WSNUVATION BIO INC | $343K |
PreviousPage 2 of 2